Aldatu Biosciences
US-based Aldatu Biosciences, founded in 2014, specializes in manufacturing diagnostic substances.
Founded
2014US-based Aldatu Biosciences, founded in 2014, specializes in manufacturing diagnostic substances.
Aldatu Biosciences, founded in 2014 and based in Cambridge, United States, specializes in the manufacturing of in vitro and in vivo diagnostic substances. The company's core mission is to develop innovative diagnostic tools to address critical global health challenges. Their product offerings include HIV drug resistance testing and pandemic preparedness solutions for viral hemorrhagic fevers such as Lassa fever, Ebola, and SARS-CoV-2 detection and variant genotyping. Aldatu aims to improve patient outcomes through advanced molecular diagnostics.
Notable figures affiliated with Aldatu Biosciences include its founders and key scientific advisors who have extensive backgrounds in biotechnology and diagnostics. The company has secured investment from prominent venture capital firms and has achieved significant milestones, such as the development of rapid and accurate diagnostic tests that have been crucial during global health crises. Aldatu's impact is evident in its contributions to public health, particularly in enhancing the detection and management of infectious diseases worldwide.
Companies similar to Aldatu Biosciences include ALT Bioscience, Adarza BioSystems, Altesa and Accelevir Diagnostics.
Aldatu Biosciences was founded in 2014.
Aldatu Biosciences' headquarters is located in Watertown, MA, US.
Aldatu Biosciences' most recent funding round was for $3M (USD) in September 2022.
As of Sep 12, 2022, Aldatu Biosciences has disclosed funding of $7.8M (USD). Undisclosed round amounts are excluded.
Aldatu Biosciences has 11 employees as of Feb 5, 2024.
